| Literature DB >> 29610119 |
Rahul Sehgal1, Erik J Stratman2, Jonathan E Cutlan3.
Abstract
Biologic agents are regarded as an effective treatment for a variety of autoimmune diseases. These drugs have an acceptable safety and tolerability profile, although an increasing number of autoimmune conditions have been reported with their use. Additionally, a variety of cutaneous diseases have been associated with their use. Here we report our experience of adverse cutaneous events with the use of biologic agents. An alternative explanation for patients presenting with adverse cutaneous events including drug interactions must be carefully investigated.Entities:
Keywords: Adverse drug events; Anti-TNF therapy; Autoimmune disease; Biologic agents; Cutaneous vasculitis
Mesh:
Substances:
Year: 2018 PMID: 29610119 PMCID: PMC6108513 DOI: 10.3121/cmr.2017.1364
Source DB: PubMed Journal: Clin Med Res ISSN: 1539-4182